RPL23 and hepatocellular carcinoma: Kaplan-Meier analysis showed that patients with higher levels of RPL23 had shorter disease-free survival (DFS; Figure 1E, HR=1.4, p=0.045) and overall survival (OS; Figure 1F, HR=1.6, p=0.0069), suggesting that upregulation of RPL23 was closely related to poor clinical outcomes in HCC.